IN192343B - - Google Patents

Info

Publication number
IN192343B
IN192343B IN540DE2000A IN192343B IN 192343 B IN192343 B IN 192343B IN 540DE2000 A IN540DE2000 A IN 540DE2000A IN 192343 B IN192343 B IN 192343B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Brij Khera
Amit Rohatgi
Om Dutt Tyagi
Yatendra Kumar
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN540DE2000 priority Critical patent/IN192343B/en
Priority to CN01812018A priority patent/CN1438989A/zh
Priority to CA002409856A priority patent/CA2409856A1/fr
Priority to BR0111193-0A priority patent/BR0111193A/pt
Priority to JP2001586239A priority patent/JP2003534310A/ja
Priority to US10/296,455 priority patent/US20040063792A1/en
Priority to PCT/IB2001/000909 priority patent/WO2001090049A1/fr
Priority to EP01929918A priority patent/EP1289928A4/fr
Priority to SK1727-2002A priority patent/SK17272002A3/sk
Priority to AU2001256595A priority patent/AU2001256595A1/en
Priority to CZ20023903A priority patent/CZ20023903A3/cs
Publication of IN192343B publication Critical patent/IN192343B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
IN540DE2000 2000-05-26 2000-05-26 IN192343B (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IN540DE2000 IN192343B (fr) 2000-05-26 2000-05-26
CN01812018A CN1438989A (zh) 2000-05-26 2001-05-24 新的无定形盐酸舍曲林
CA002409856A CA2409856A1 (fr) 2000-05-26 2001-05-24 Nouvelle forme amorphe d'hydrochlorure de sertraline
BR0111193-0A BR0111193A (pt) 2000-05-26 2001-05-24 Nova forma amorfa de hidrocloreto de sertralina e processo de preparação da mesma.
JP2001586239A JP2003534310A (ja) 2000-05-26 2001-05-24 塩酸セルトラリンの新規な非結晶形態
US10/296,455 US20040063792A1 (en) 2000-05-26 2001-05-24 Novel amorphous form of sertraline hydrochloride
PCT/IB2001/000909 WO2001090049A1 (fr) 2000-05-26 2001-05-24 Nouvelle forme amorphe d'hydrochlorure de sertraline
EP01929918A EP1289928A4 (fr) 2000-05-26 2001-05-24 Nouvelle forme amorphe d'hydrochlorure de sertraline
SK1727-2002A SK17272002A3 (sk) 2000-05-26 2001-05-24 Amorfná forma sertralín hydrochloridu
AU2001256595A AU2001256595A1 (en) 2000-05-26 2001-05-24 Novel amorphous form of sertraline hydrochloride
CZ20023903A CZ20023903A3 (cs) 2000-05-26 2001-05-24 Nová amorfní forma sertralin hydrochloridu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN540DE2000 IN192343B (fr) 2000-05-26 2000-05-26

Publications (1)

Publication Number Publication Date
IN192343B true IN192343B (fr) 2004-04-10

Family

ID=11097055

Family Applications (1)

Application Number Title Priority Date Filing Date
IN540DE2000 IN192343B (fr) 2000-05-26 2000-05-26

Country Status (11)

Country Link
US (1) US20040063792A1 (fr)
EP (1) EP1289928A4 (fr)
JP (1) JP2003534310A (fr)
CN (1) CN1438989A (fr)
AU (1) AU2001256595A1 (fr)
BR (1) BR0111193A (fr)
CA (1) CA2409856A1 (fr)
CZ (1) CZ20023903A3 (fr)
IN (1) IN192343B (fr)
SK (1) SK17272002A3 (fr)
WO (1) WO2001090049A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500987B1 (en) 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
US6495721B1 (en) 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
SK8872002A3 (en) 1999-12-21 2002-12-03 Teva Pharma Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
WO2002096859A1 (fr) * 2001-05-31 2002-12-05 Orion Corporation Fermion Procede de fabrication de chlorhydrate de sertraline polymorphe de forme ii
US6897340B2 (en) 2002-04-29 2005-05-24 Teva Pharmaceutical Industries Ltd. Processes for preparation of polymorphic form II of sertraline hydrochloride
JP2007502329A (ja) 2003-05-23 2007-02-08 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド セルトラリン組成物
US7189876B2 (en) 2003-07-15 2007-03-13 Recordati Industria Chimica E Farmaceutica S.P.A. Methods for preparing sertraline hydrochloride polymorphs
WO2005012224A1 (fr) * 2003-07-15 2005-02-10 Recordati Industria Chimica E Farmaceutica S.P.A. Chlorhydrate de sertraline de forme ii et procedes de preparation associes
WO2006081515A2 (fr) * 2005-01-27 2006-08-03 Teva Pharmaceutical Industries Ltd. Polymorphes d'hydrochlorure de duloxetine
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
DE102008039271A1 (de) * 2007-12-23 2009-06-25 Euromed Sa Neuer Mariendistelextrakt, Verfahren zur Herstellung und Verwendung
EP2665363B1 (fr) * 2011-01-21 2019-12-25 Avery Dennison Corporation Adhesif contenant du gluconate de chlorhexidine
US11058793B2 (en) 2011-05-16 2021-07-13 Avery Dennison Corporation Adhesive containing microparticles
PL2954019T3 (pl) 2013-02-07 2019-01-31 Avery Dennison Corporation Kleje przeciwbakteryjne o ulepszonych właściwościach
US11213432B2 (en) 2013-03-15 2022-01-04 Avery Dennison Corporation Transparent cover dressing application system and inclusion of label strip
EP3151813B1 (fr) 2014-06-05 2020-12-09 Avery Dennison Corporation Articles à agent actif concentré au niveau de la surface de contact avec un substrat et procédés associés

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5166437A (en) * 1989-03-03 1992-11-24 Orion-Yhtyma Oy Process for the preparation of fluoxetine
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5734083A (en) * 1996-05-17 1998-03-31 Torcan Chemical Ltd. Sertraline polymorph
JP2000026378A (ja) * 1998-07-03 2000-01-25 Sumika Fine Chemicals Co Ltd 塩酸セルトラリンの製法
EP1133459B1 (fr) * 1998-11-27 2006-01-11 Teva Pharmaceutical Industries Ltd. Chlorhydrate de sertraline forme v
US6500987B1 (en) * 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
TWI260315B (en) * 1999-10-29 2006-08-21 Ciba Sc Holding Ag Polymorphic forms of sertraline hydrochloride

Also Published As

Publication number Publication date
BR0111193A (pt) 2003-07-29
CN1438989A (zh) 2003-08-27
US20040063792A1 (en) 2004-04-01
WO2001090049A1 (fr) 2001-11-29
CA2409856A1 (fr) 2001-11-29
EP1289928A4 (fr) 2005-06-08
CZ20023903A3 (cs) 2003-05-14
SK17272002A3 (sk) 2003-05-02
JP2003534310A (ja) 2003-11-18
AU2001256595A1 (en) 2001-12-03
EP1289928A1 (fr) 2003-03-12

Similar Documents

Publication Publication Date Title
BE2011C041I2 (fr)
BE2010C008I2 (fr)
BE2009C057I2 (fr)
BRPI0113085B8 (fr)
JP2001075828A5 (fr)
BRPI0110940B8 (fr)
JP2001027643A5 (fr)
BE2014C025I2 (fr)
JP2001012530A5 (fr)
BY5768C1 (fr)
BRPI0000763B8 (fr)
CN3136619S (fr)
CN3141398S (fr)
AU2000276780A8 (fr)
AU2000270908A8 (fr)
BY4905C1 (fr)
AU2000256695A8 (fr)
CL2001002979A1 (fr)
CN3135488S (fr)
CN3135489S (fr)
CN3135584S (fr)
CN3135585S (fr)
CN3135789S (fr)
CN3136262S (fr)
AU2000280319A8 (fr)